These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24526003)

  • 1. Hospital ownership and drug utilization under a global budget: a quantile regression analysis.
    Zhang JH; Chou SY; Deily ME; Lien HM
    Int Health; 2014 Mar; 6(1):62-9. PubMed ID: 24526003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global budgets and provider incentives: hospitals' drug expenditures in Taiwan.
    Chou SY; Deily ME; Lien HM; Zhang JH
    Adv Health Econ Health Serv Res; 2010; 22():103-22. PubMed ID: 20575230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The drug budget silo mentality: the French case.
    Le Pen C
    Value Health; 2003; 6 Suppl 1():S10-9. PubMed ID: 12846922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provider responses to a global budgeting system: The case of drug expenditures in Taiwan hospitals.
    Chou SY; Dearden JA; Deily ME; Lien HM
    Health Econ; 2020 Oct; 29(10):1270-1278. PubMed ID: 33463861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of global budgeting on treatment intensity and outcomes.
    Kan K; Li SF; Tsai WD
    Int J Health Care Finance Econ; 2014 Dec; 14(4):311-37. PubMed ID: 25012589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of global budget on the diffusion of innovations: the example of positron emission tomography in Taiwan.
    Yang CM
    BMC Health Serv Res; 2018 Nov; 18(1):905. PubMed ID: 30486808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determinants of health care expenditure toward the end of life: evidence from Taiwan.
    Chang S; He Y; Hsieh CR
    Health Econ; 2014 Aug; 23(8):951-61. PubMed ID: 23843210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital response to a global budget program under universal health insurance in Taiwan.
    Cheng SH; Chen CC; Chang WL
    Health Policy; 2009 Oct; 92(2-3):158-64. PubMed ID: 19361879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to achieving value in drug spending in a decentralized country: the Spanish case.
    Antoñanzas F
    Value Health; 2003; 6 Suppl 1():S52-63. PubMed ID: 12846926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Providers' responses to global budgeting in Taiwan: what were the initial effects?
    Chen FJ; Laditka JN; Laditka SB; Xirasagar S
    Health Serv Manage Res; 2007 May; 20(2):113-20. PubMed ID: 17524223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of resource allocation in the hospital sector after global budgeting under National Health Insurance.
    Kreng V; Yang SW
    Chin Med J (Engl); 2013; 126(15):2900-6. PubMed ID: 23924465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in Germany.
    Schwermann T; Greiner W; v d Schulenburg JM
    Value Health; 2003; 6 Suppl 1():S20-30. PubMed ID: 12846923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider Behavior Under Global Budgeting and Policy Responses: An Observational Study on Eye Care Services in Taiwan.
    Chang CK; Xirasagar S; Chen B; Hussey JR; Wang IJ; Chen JC; Lian IeB
    Inquiry; 2015; 52():. PubMed ID: 26324511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between for-profit hospital ownership and increased Medicare spending.
    Silverman EM; Skinner JS; Fisher ES
    N Engl J Med; 1999 Aug; 341(6):420-6. PubMed ID: 10432327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agency problems of global budget system in Taiwan's National Health Insurance.
    Yan YH; Yang CW; Fang SC
    Health Policy; 2014 May; 116(1):37-50. PubMed ID: 24598279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital ownership and performance: evidence from stroke and cardiac treatment in Taiwan.
    Lien HM; Chou SY; Liu JT
    J Health Econ; 2008 Sep; 27(5):1208-23. PubMed ID: 18486978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug use in relation to clinical activities as an instrument for prospective drug budgeting. The Belgian experience.
    Closon MC; Crott R; Even-Adin D
    Pharmacoeconomics; 1996 Mar; 9(3):246-63. PubMed ID: 10160100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug cost containment at a large teaching hospital.
    Pillans PI; Conry I; Gie BE
    Pharmacoeconomics; 1992 May; 1(5):377-82. PubMed ID: 10147002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does state budget pressure matter for uncompensated care spending in hospitals? Findings from Texas and California.
    Chang J; Patel I; Suh WS; Lin HC; Kim S; Balkrishnan R
    Int J Health Plann Manage; 2012; 27(2):88-103. PubMed ID: 22513523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does a global budget superimposed on fee-for-service payments mitigate hospitals' medical claims in Taiwan?
    Hsu PF
    Int J Health Care Finance Econ; 2014 Dec; 14(4):369-84. PubMed ID: 24870263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.